The Oil & Gas Journal, first published in 1902, is the world's most widely read petroleum industry publication. OGJ delivers international oil and gas industry news; analysis of issues and events; practical technology for design, operation, and maintenance of oil and gas operations; and important statistics on energy markets and industry activity.

OGJ is edited to meet the needs of engineers, geoscientists, managers, and executives throughout the oil and gas industry. It is part of Endeavor Business Media, Nashville, Tenn., which also publishes Offshore Magazine.

Endeavor Business Media’s Petroleum Group also produces targeted e-Newsletters; hosts global conferences and exhibitions, seminars, and forums; and publishes directories, technical books, print and electronic databases, surveys, and maps.

Additional Information

Website & Technical Help

For help with subscription purchases or refunds, or trouble logging into the paid subscription content on www.ogj.com, please contact Customer Service at [email protected] or call 1-847-559-7598.

For more customer service information, please click here.

Astraglass Innovations and Scalables Partner to Launch AI-Powered, Modular Bioreactor Platform

VINELAND, NJ / ACCESS Newswire / September 29, 2025 / Astraglass Innovations, a leading North American manufacturer of precision scientific glassware, and Scalables, the pioneer behind the Daisy modular lab-automation platform, announced a strategic collaboration to deliver a next-generation bioreactor system that combines Astraglass's advanced vessels with Scalables' AI-driven controller technology.

This AI-enabled, modular bioreactor platform is designed to help pharmaceutical and biotechnology companies accelerate discovery, streamline operations, and reduce costs. By combining Astraglass's precision-engineered vessels with Daisy's snap-together automation hardware and adaptive AI software, the system offers real-time optimization, predictive insights, and effortless scalability-from benchtop experiments to pilot-scale manufacturing.

"Traditional bioreactors rely on programmable controllers for managing temperature, agitation, gas flow, pH, and nutrient feeds," said Dr. Subu Natesan, CEO of Astraglass Innovations. "But they still require constant human oversight and lack the ability to learn. By integrating Scalables' digital control systems, we're bringing AI-powered automation into the labs of the future."

Dr. Hür Köser, Founder and CEO of Scalables, added: "Scalables exists to remove experimentation bottlenecks. Teaming with Astraglass lets us extend our Daisy architecture to bioreactors, giving scientists an intelligent, drop-in upgrade path that scales seamlessly from research to production."

The platform addresses a critical challenge in pharma and biotech: how to replicate experiments reliably while scaling them efficiently and cost-effectively. With AI-enabled adaptive control and modular hardware, researchers can improve reproducibility, accelerate timelines, and de-risk the transition from discovery to manufacturing.

Biopharma industry leader Stephen Grant, who has worked with both companies, sees the partnership as a timely innovation for the sector: "Both Astraglass and Scalables are thinking outside the box, bringing independent technologies together to create a new and innovative way to run bioreactor-based processes. It's a breakthrough that could redefine how R&D and manufacturing teams operate."

About Astraglass Innovations

Astraglass Innovations is a certified small business specializing in high-precision borosilicate and quartz glassware for life sciences, chemistry, and process research markets. Its portfolio spans custom vessels, reactor components, and turnkey glass assemblies that meet the most demanding analytical and production needs.

About Scalables

Scalables provides AI-enabled, snap-together automation hardware and software that let any lab set up, run, and optimize workflows in minutes-at a fraction of the cost of legacy robots. Founded by MIT-trained physicist and engineer Dr. Hür Köser, Scalables' patent-pending Daisy platform is already powering rapid-iteration research at universities and biotech startups.

Media Contact
Lily Vining
lily@levelupwithlily.com
(203) 707-9091

For Technical Questions:

For Scalables: info@scalables.com

For AstraGlass: sales@astraglassinnov.com

SOURCE: Scalables



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.